Placeholder graphic Placeholder graphic

Hematology-Oncology

print page content

Pediatric Clinical Trials

Trials for Brain TumorsTrials for Sarcomas
Trials for Leukemia/LymphomaTrials for Other Solid Tumors
Non-Treatment Trials  

Clinical Trials - Brain Tumors
 
 
 MEDULLOBLASTOMA
 
  For Information: 617-724-1836
   
 
  Protocol #: MGH 99-271 Medullo
  Investigator: Nancy J. Tarbell, MD
  Description: Proton Therapy for Medulloblastoma and Other CNS Tumors –
A Prospective Look at Acute and Long-Term Sequelae
 
 
  For Information: 617-724-0857
 
  Protocol #: COG ACNS0331
  Investigator: David H. Ebb, MD
  Description: Standard Risk Medulloblastoma
     
 EPENDYMOMA
     
  For Information: 617-724-0857
     
  Protocol #: COG ACNS0121
  Investigator: David H. Ebb, MD
  Description: Localized Ependymomas
    

 

 
 BRAIN STEM Tumors or GLIOMAS
 
  For Information: 617-724-0857
 
  Protocol #: COG ACNS0423
  Investigator: David H. Ebb, MD
  Description: 

Radiation Therapy with Temozolomide and Lomustine in High Grade Gliomas

 
  For Information  617-724-0857
     
  Protocol #: PBTC 021
  Investigator: David H. Ebb, MD
  Description: 

Capecitabine and Radiation Therarpy in Newly Diagnosed Brain Stem and High Grade Gliomas

 
 BRAIN TUMORS - RECURRENT OR PROGRESSIVE
 
  For Information: 617-724-0857
 
  Protocol #: PBTC 015
  Investigator: David H. Ebb, MD
  Description: O6-Benzylguanine and Temozolomide in Recurrent or Progressive High-Grade Gliomas or Brain Stem Gliomas
 
Back to the Top


Trials for Pediatric Leukemia/Lymphoma
 
 
 LEUKEMIA – Precursor B Cell
 
  For Information: 617-724-0857
 
  Protocol #: COG AALL0331
  Investigator: Alison M. Friedmann, MD
  Description: Standard-Risk Acute Lymphoblastic Leukemia
 
  For Information:  617-724-0857
     
  Protocol #: COG AALL0232
  Investigator: Alison M. Friedmann, MD
  Description: High-Risk Acute Lymphoblastic Leukemia
 
 HODGKIN DISEASE
 
  For Information: 617-724-0857
 
  Protocol #: HOD99
  Investigator: Howard J. Weinstein, MD
  Description: Risk-Adapted Therapy in Pediatric Hodgkin Disease
 
  For Information: 617-724-0857
     
  Protocol #: COG AHOD0121
  Investigator: Alison M. Friedmann, MD
  Description: Stem Cell Rescue in Refractory/Relapsed Hodgkin
   
  For Information: 617-724-0857
  Protocol #: HOD05
  Investigator: Alison M. Friedmann, MD
  Description: Intermediate Risk Hodgkin Disease
     
 NON-HODGKIN LYMPHOMA
     
  For Information: 617-724-0857
     
  Protocol #: COG ANHL01P1
  Investigator: Howard Weinstein, MD
  Description: Advanced B-Cell Leukemia/Lymphoma
     
 
Back to the Top


Clinical Trials - Sarcomas
 
 
 OSTEOSARCOMA
 
  For Information: 617-724-0857
 
  Protocol #: COG AOST0121
  Investigator: David H. Ebb, MD
  Description: Trastuzumab for HER2+ Metastatic Osteosarcoma
 
 RHABDOMYOSARCOMA
 
  For Information: 617-724-0857
 
  Protocol #: COG ARTS0331
  Investigator: Alison M. Friedmann, MD
  Description: Low-Risk Rhabdomyosarcoma
 
  For Information  617-724-0857
 
  Protocol #: 04-188
  Investigator: Torunn Yock, MD
  Description: Phase II trial of Proton Radiation for the treatment of Pediatric Rhabdomyosarcoma
 
Back to the Top


Clinical Trials - Other Solid Tumors
 
 
 RENAL TUMORS
 
  For Information: 617-724-0857
 
  Protocol #: COG AREN0321
  Investigator: Mary Huang, MD
  Description: High Risk Renal Tumors
     
 
Non-Treatment Trials  
  
 
 SOLID TUMORS
     
  For Information: 617-724-0857
     
  Protocol #: ACRIN 6660
  Investigator: Alison Friedmann,MD
  Description: Whole-Body MRI in Pediatric Malignancies